🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sensory Neurography and S2PD After Digital Nerve Injury

Recruitingn/aAges 20 Years - 60 YearsAllCecilia Mellstrand Navarro
NCT07904286 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical comparative cross sectional study, is to investigate neurophysiological findings and S2PD (static two point discrimination test) measurements after digital nerve injury. The main aim is to find out if there are measurable neurophysiological differences in fingers following digital nerve injury that correlate with discriminative sensory function (S2PD) as experienced by the patient. Secondary aim is to investigate how well neurophysiological measurements predict specific S2PD values in the affected fingers. Participants with a sutured digital nerve injury will be examined with neurophysiology and S2PD testing. Both injured finger and corresponding uninjured finger on the other hand will be examined, i.e participants will be their own control. Prior to the study the investigators will perform a test-re-test study on ten participants to ensure that the method is

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Injury: One year or more prior to inclusion Injured finger: digit II, III or radial dig IV Level of injury: base or middle phalanx Age at injury\>20 Age at inclusion\<60 Exclusion Criteria: Neurologic disease Dementia Cognitive disability Severe psychiatric disorder (not be able to participate) Ongoing drug abuse Not understanding swedish language History of carpal tunnel syndrome Negative experience of electric stimulation
💊

What it tests

  • Sensory neurography
  • Static two point discrimination test, S2PD
📍

Where

2 sites
Karolinska Institutet Södersjukhuset, Department of clinical research and education
Stockholm, Sweden
South General Hospital
Stockholm, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy